• Explore /
  • Poster
  • / Genetically engineered T-cell therapy for HPV-associated epithelial cancers: A first in human, phase I/II clinical trial.

Genetically engineered T-cell therapy for HPV-associated epithelial cancers: A first in human, phase I/II clinical trial.

Abstract Poster

Authors

null

Stacey L. Doran

National Cancer Institute at the National Institutes of Health, Bethesda, MD

Stacey L. Doran , Sanja Stevanovic , Sabina Adhikary , Jared J. Gartner , Li Jia , Mei Li M. Kwong , William C Faquin , Steven Feldman , Robert Somerville , Richard Mark Sherry , James C. Yang , Steven A. Rosenberg , Christian S. Hinrichs

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Cellular Immunotherapy

Clinical Trial Registration Number

NCT02280811

Citation

J Clin Oncol 36, 2018 (suppl; abstr 3019)

DOI

10.1200/JCO.2018.36.15_suppl.3019

Abstract #

3019

Poster Bd #

233

Abstract Disclosures

Similar Posters

First Author: Nisha Nagarsheth

First Author: Christian S. Hinrichs

First Author: Suzanne Phillips

First Author: Kedar Kirtane